These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
458 related items for PubMed ID: 1434754
1. Antiprogestin drugs: ethical, legal and medical issues. Cook RJ, Grimes DA. Law Med Health Care; 1992; 20(3):149-53. PubMed ID: 1434754 [Abstract] [Full Text] [Related]
2. Antiprogestin drugs: ethical issues. Macklin R. Law Med Health Care; 1992; 20(3):215-9. PubMed ID: 1434763 [Abstract] [Full Text] [Related]
3. RU 486 in France and England: corporate ethics and compulsory licensing. Boland R. Law Med Health Care; 1992; 20(3):226-34. PubMed ID: 1434766 [Abstract] [Full Text] [Related]
4. RU-486: legal and policy issues confronting the Food and Drug Administration. Muhl C. J Leg Med; 1993 Jun; 14(2):319-47. PubMed ID: 8340714 [Abstract] [Full Text] [Related]
5. Updating RU 486 development. Baulieu EE. Law Med Health Care; 1992 Jun; 20(3):154-6. PubMed ID: 1434755 [Abstract] [Full Text] [Related]
11. Studying the acceptability and feasibility of medical abortion. Winikoff B, Coyaji K, Cabezas E, Coyaji B, Krishna U, de la Concepcion O, Eschen A, Sivin I, Brady M. Law Med Health Care; 1992 Jun; 20(3):195-8. PubMed ID: 1434760 [Abstract] [Full Text] [Related]
18. Great Britain second country to allow use of RU-486. Smith W. Plan Parent Eur; 1991 Sep; 20(2):20. PubMed ID: 12284548 [Abstract] [Full Text] [Related]